Although a number of studies have focused on the higher ethyl pyruvate antioxidative activity than its sodium salt under various stress conditions, and the greater protective properties of the ester form have been suggested as the effect of better cell membrane penetration, the molecular mechanism has remained unclear. The aim of the present study was therefore to compare the antioxidative activities of sodium and ethyl pyruvate under in vitro conditions by using a liver homogenate as the model for cell membrane transport deletion. The potential effect of ethanol was also evaluated, and hypochlorous acid was used as an oxidant. Our data indicate the concentration-dependent scavenging potency of both sodium and ethyl pyruvate, with the ester having higher activity. This effect was not related to the presence of ethanol. Better protection of the liver homogenate by ethyl pyruvate was also apparent, despite the fact that cell membrane transport was omitted.
Pyruvate is a product of carbohydrate metabolism which has protected a number of tissues in various stress models. [1] [2] [3] Its effectiveness has been explained by several mechanisms, including increased ATP phosphorylation potential, enhanced sarcoplasmic reticular calcium ion exchange, closure of mitochondrial permeability transition pores, and decreased cytoplasmic NADH/NAD þ ratio (see ref. 4 for a review). However, particular attention has been focused on its capacity to scavenge reactive oxygen species (ROS). The antioxidative properties of pyruvate stem in part from the -ketocarboxylate structure.
5) It reduces hydrogen peroxide to water 6) and scavenges the hydroxyl radical 7) by non-enzymatic decarboxylation.
A number of studies in recent years have been focused on ethyl pyruvate (EtP), an aliphatic ester produced from ethanol (EtOH) and pyruvate (see ref. 8 for a review). Pyruvate in an aqueous solution is transformed into parapyruvate, an inhibitor of the tricarboxylic acid cycle, 9) whereas EtP is a more stable compound. Despite its greater stability, EtP also appeared to be more effective than sodium pyruvate (NaP) under various stress conditions. [10] [11] [12] [13] [14] [15] [16] An in vivo model of LPS-induced hepatocellular injury indicated both EtP and NaP to have protective properties, although EtP was more efficacious.
12) It has also been shown that EtP effectively protected liver from the injury induced by acute alcohol administration. 17) Moreover, strong inhibition of ROS formation by EtP has been reported under hypoxic and ischemia-reperfusion conditions. 18, 19) Increased myeloperoxidase (MPO) activity has been observed under ischemia and reperfusion of the liver, 20) MPO producing hypochlorous acid (HOCl), a strong oxidant which plays a key role in the defense system. However, the generation of such a strong oxidant has also been implicated in tissue injury (see ref. 21 for a review). A very recent study has shown that partial liver ischemia induced oxidative stress in both non-ischemic parts and ischemic parts. 22) Oxidative stress in nonischemic lobes may be attributed to the immune response generated by Kuppfer cells and to neutrophils which includes the formation of HOCl by MPO. 23) Although EtP has been well established as the more effective agent, the molecular mechanism remains unclear. A number of hypotheses have recently been reviewed. 24) It has been suggested that the observed differences were due to better cell membrane penetration by the ester form of carboxylic acid. Pyruvate needs a monocarboxylate transporter, 25) whereas EtP can easily cross the cell membrane. 26) EtP is cleaved by esterase to pyruvate and EtOH inside the cell, whereby EtP delivers pyruvate to the cells and augments the intracellular EtOH level which can also act as an antioxidant. 27) Another hypothesis has suggested that the protective effect of EtP resulted from its direct antioxidative activity. 24 29) Moreover, it has been shown in a chemiluminescence study that EtP was more effective for H 2 O 2 scavenging than NaP. 30) The aim of this study was therefore to compare the antioxidative activities of sodium and ethyl pyruvate under in vitro conditions, using a liver homogenate as the model for cell membrane transport deletion. The potential effect of ethanol was also evaluated.
Materials and Methods
Materials. All reagents were obtained from Sigma-Aldrich, unless otherwise stated. Solutions of the compounds were prepared freshly every day by dilution in a 100 mM phosphate buffer (pH 7.4). The concentrations used in the study were based on previous works. 7, 10, 13, 15) Ascorbic acid was used as a reference antioxidant in all the experiments. A stock solution of NaOCl was prepared in water, and its concentration was determined spectrophotometrically at 290 nm, using a molar extinction coefficient of 350 M À1 cm À1 .
31)
Luminescence analysis. Chemiluminescence (CL) measurements were performed by using GloMaxÔ 20/20 (Promega Corp.) according to the method previously described. 32) Luminol and a test substance were preincubated in a 100 mM phosphate buffer (pH 7.4), and then NaOCl was injected. The final concentration of both luminol and NaOCl was 100 mM. The kinetics of light emission were followed for 2 s, with individual measuring times of 0.1 s. All measurements were performed at 25 C.
Spectrophotometric analysis. ABTS (2,2 0 -azinobis(3-ethylbenzothiazoline-6-sulfonate)) was used in this assay to measure the scavenging activity of the compounds. Each sample prepared in a 100 mM phosphate buffer (pH 7.4) was mixed with the ABTS solution (175 mM final concentration). The phosphate buffer alone was used for the blank sample. The formation of the ABTS radical cation (ABTS þ ) was induced by adding NaOCl (600 mM final concentration), the change in absorbance at 405 nm being measured in time. 33) All measurements were performed at 25 C with a Super Aquarius CE9200 (Cecil Instruments).
Fluorescence analysis. DPBF (1,3-diphenylisobenzofuran) was preincubated for 5 min in a 100 mM phosphate buffer with 0.5% Triton X-100. The DPBF (2 mM final concentration) fluorescence was then recorded at an excitation wavelength of 410 nm and emission wavelength at 455 nm according to the method previously described. 34, 35) DPBF fluorescence quenching was obtained after adding NaOCl (50 mM final concentration). The same procedure was performed in the presence of EtP, NaP, EtOH, and NaP þ EtOH. All measurements were taken at 25 C with an LS50-B fluorescence spectrophotometer (Perkin Elmer).
Liver preparation and analysis. The experiments were approved by the Local Animal Ethics Committee and conducted in accordance with the Declaration of Helsinki. Tissues were extracted from Wistar rats (5 months old) following anesthesia with sodium pentobarbital (100 mgÁkg À1 i.p.). The samples were frozen and stored at À80 C until needed for analysis. The liver sample was minced and homogenized in a 100 mM potassium phosphate buffer at pH 7.4 prior to a chemical assay. The homogenate was then centrifuged for 10 min at 600 g and 4 C to remove the cellular debris. 36) The protein content of the supernatant was evaluated by the method of Lowry et al.
37) The scavenging properties of each compound was tested in the liver homogenate (1 mg of protein/mL) by DPBF fluorescence quenching and determination of the sulfhydryl groups (SH).
The fluorescence analysis was performed as just described, the liver homogenate being preincubated for 5 min with DPBF. Each test compound was then added, and the sample was mixed for the following 60 s. DPBF fluorescence quenching was started by adding 500 mM NaOCl (final concentration).
The sulfhydryl groups were determined after incubating the liver homogenate for 60 min at 37 C in the presence of a test compound (5 mM) and 300 mM NaOCl (final concentration). Ellman's method was employed for estimating SH 38) by incubating a sample with 100 mM 5,5 0 -dithiobis-(2-nitrobenzoic acid) (DTNB, Wako Pure Chemicals) at room temperature for 60 min. The absorbance was determined at 412 nm, measurements being performed with a Super Aquarius CE9200 (Cecil Instruments).
Data reporting. The data presented as the percentage (%) inhibition were calculated as % I ¼ 100 À ðS sample Â 100=S blank Þ where S sample is the area under the curve of the absorbance, fluorescence, or chemiluminescence signal obtained for a sample in the presence of NaP, EtP, EtOH or NaP þ EtOH, and S blank is the area under the curve obtained for the control sample. 30) Statistical analysis. Each result is the average of at least 6 measurements and is expressed as the mean AE SD. Comparisons among groups were conducted by one-way ANOVA and Tukey's post hoc analysis with STATISTICA software (StatSoft). The level of significance was determined at p < 0:01.
Results
The kinetics of the luminol-CL signal induced by HOCl are presented in Fig. 1 . The data indicate a concentration-dependent scavenging potency of both NaP (panel A) and EtP (panel B), with the ethyl ester having the higher activity. Almost 50% inhibition of the CL signal was obtained with 10 mM NaP, and with 1 mM EtP. A similar result was obtained with 0.1 mM ascorbic acid (not shown). EtOH at the given concentrations had no effect (not shown).
A spectrophotometric method was employed to confirm the HOCl-scavenging activity of NaP and EtP. As shown in Fig. 2 , both compounds reduced ABTS oxidation, EtP again being more effective than NaP. Under the same conditions, 0.1 mM ascorbic acid inhibited ABTS oxidation by 75:4 AE 3:1% (not shown).
The DPBF fluorescence quenching induced by HOCl was inhibited in the presence of EtP and NaP. Almost complete inhibition was obtained with 5 mM EtP, and only 10% inhibition with the same concentration of NaP (Fig. 3) . EtOH was ineffective either alone or in the presence of NaP. This model resulted in 0.1 mM ascorbic acid inhibiting DPBF quenching by 87:1 AE 3:8% (not shown).
EtP, NaP, EtOH, and NaP þ EtOH at 5 mM respectively inhibited DPBF quenching in the liver homogenate by 24:1 AE 7:3%, 2:1 AE 3:5%, 4:3 AE 5:5%, and 4:2 AE 2:8% (Fig. 4) . The same concentration of ascorbic acid inhibited quenching by 82:8 AE 3:7% (not shown).
Similar results were found for SH oxidation of the liver homogenate (Fig. 5) . The presence of 5 mM EtP inhibited SH oxidation by 26:2 AE 7:8%, whereas NaP did so by 6:8 AE 4:5% (p < 0:001). EtOH alone, or in the presence of NaP had no scavenging activity (Fig. 5) . Ascorbic acid gave 77:1 AE 4:2% inhibition (not shown).
Discussion
The main findings of our study are that pyruvate could directly react with HOCl, and that the antioxidative activity of the ethyl ester form was higher than of the sodium salt. Moreover, HOCl scavenging by EtP in the liver homogenate was more effective, despite the fact that cell membrane transport had been omitted.
Fedeli et al. have indicated by a chemiluminescence assay that EtP was a more potent scavenger of H 2 O 2 and O 2 À than NaP. 30) Our data confirm the higher scavenging ability of EtP in the HOCl oxidant model (Figs. 1  and 2 ).
The well-described differences in the pharmacological effects of EtP and NaP [10] [11] [12] [13] [14] [15] [16] may reflect the greater lipophilicity of EtP. 16) Our data presented in Fig. 3 are consistent with the physicochemical property hypothesis related to differing lipophilicity. DPBF is a probe which is preferentially located in a hydrophobic domain and loses its fluorescence after oxidation. The HOCl-induced fluorescence quenching of DPBF was inhibited more HOCl in the Presence of EtP ( ), NaP ( ), EtOH ( ), and NaP þ EtOH ( ). Ã p < 0:001 as compared with NaP, EtOH, and NaP þ EtOH at equal concentrations; z p < 0:001 as compared to EtOH at an equal concentration. HOCl in a Liver Homogenate in the Presence of 5 mM EtP, NaP, EtOH, or NaP þ EtOH. Ã p < 0:001 as compared to NaP, EtOH, and NaP þ EtOH. by HOCl in the Presence of 5 mM EtP, NaP, EtOH, or NaP þ EtOH. Ã p < 0:001 as compared to NaP, EtOH, and NaP þ EtOH.
effectively in the presence of EtP than NaP (Figs. 3 and  4) . However, similar behavior was apparent in the models with lipid micelles excluded ( Figs. 1 and 2 ). The higher lipophilicity of EtP may be attributable to its better penetration than pyruvate through a biological membrane. 10, 13, 14, 26, 39) We used a liver homogenate in our study to avoid the membrane cell barrier. The data presented in Fig. 5 indicate better inhibition of SH oxidation by EtP than by an equimolar concentration of NaP or NaP in the presence of EtOH (p < 0:001), despite the fact that there was no cell membrane transport employed in this model.
Recent in vitro studies have used cultured human cells exposed to pro-inflammatory agents. 15, 40) EtOH was completely ineffective in reducing an inflammatory reaction in all the assays when an equimolar concentration was used, 40) and significantly less potent than EtP at a several-fold higher concentration.
15) It has also been established that an ester linkage was not essential for the protective effects of pyruvate derivatives. 16) Rats subjected to multivisceral ischemia as a reperfusion model have shown that benzoylformic acid (the anion of a carboxylic acid) decreased damage similarly to EtP. Our data confirm these observations. EtOH by itself did not exhibit reactivity with HOCl (Figs. 2-5) . Moreover, the presence of EtOH did not elevate the antioxidative activity of NaP, and both these compounds together were still much less effective than EtP (Figs. 2-5) .
Our results clearly show that the higher EtP reactivity with HOCl was not due to the presence of an ester linkage, neither was EtOH by itself (Figs. 2-5) . A recent in vitro study by Giese and Lecher has demonstrated that, under physiological pH conditions, the creatine ethyl ester was not simply hydrolyzed to creatine and ethanol. 41) Instead, it underwent nonenzymatic transformation into creatinine. We therefore cannot exclude the possibility that EtP dilution in a buffer at pH 7.4 gave some other compound which acted as an antioxidant.
The scavenging of HOCl that is presented in our study may be important under pathophysiological conditions, in which an oxidative burst occurs due to phagocyte activation. The administration of EtP in various experimental models was protective after the induction of stress. 15, [42] [43] [44] [45] [46] A prolonged survival time in a lethal model of endotoxic shock has been observed when the EtP treatment was started after the inflammatory response. 43) Yu et al. have also demonstrated the neuroprotective effect of EtP with cerebral ischemia. 42) A significant reduction in infarct volume was evident even when EtP was administered as late as 24 h after the arterial occlusion.
In conclusion, this study has shown that EtP provided better scavenging of HOCl than NaP did. This effect was not related to the presence of EtOH. Better protection was apparent in a liver homogenate, despite the fact that cell membrane transport had been excluded.
